相关实验视频

Updated: Sep 11, 2025

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

识别和解读针对DTYMK的新型化合物动态:对胰腺癌的潜在瘤基因

Abdulaziz A Aloliqi¹, Hamid G Mohamed¹

¹Department of Basic Health Sciences, College of Applied Medical Sciences, Qassim University, Buraydah, Saudi Arabia.

Journal of molecular graphics & modelling

|August 17, 2025

概括

计算研究确定了AZD2281,MDV3100和卡巴马西平作为胰腺癌 (PC) 的潜在治疗方法. 这些药物化合物对DTYMK标具有很高的结合亲和力和稳定性,需要进一步的实验验证.

科学领域:

计算机化药物发现.
分子建模分子建模
在瘤学瘤学.

背景情况:

脱氧胺基酸激酶 (DTYMK) 在胰腺癌 (PC) 进展中至关重要.
准DTYMK为PC提供了一个潜在的治疗策略.

研究的目的:

确定针对DTYMK用于胰腺癌治疗的新型抗癌药物化合物.
用计算方法评估潜在药物候选物的结合亲和力和稳定性.

主要方法:

利用了分子对接,MD模拟和药理动力学分析.
选了FDA批准的抗癌药物库 (1745种化合物).
使用Lipinski的五项规则评估药物相似性,并通过RMSD,盐桥,PCA和MMGB/PBSA计算分析复杂稳定性.

主要成果:

确定了AZD2281,MDV3100和卡巴马泽平作为具有高对接分数 (-9.8到-9.6千卡/mol) 的有希望的候选药物.
所有已识别的化合物都遵守了利宾斯基的五项规则,这表明它们具有良好的类似药物的特性.
AZD2281表现出卓越的稳定性和结合一致性,得到RMSD,MMGB/PBSA和分析的支持.

结论:

这项in silico研究成功地确定了针对DTYMK的胰腺癌的新疗法化合物 (AZD2281,MDV3100,卡巴马泽平).
已识别的化合物需要对其有效性和潜在的临床应用进行实验验证.
进一步的修改可能会增强这些化合物的针对DTYMK的准能力.

关键词:

癌症治疗治疗癌症治疗在 DTYMKKK 的位置上.分子对接模拟分子对接模拟分子向疗法分子向疗法药理动力学药理动力学这是一个RMSD.

更多相关视频

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays

Published on: September 19, 2018

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line

Published on: April 11, 2025

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...